Navigation Links
Summer Street Research Partners Closes Financing for ImmunoCellular Therapeutics, Ltd.
Date:3/4/2011

BOSTON, March 4, 2011 /PRNewswire/ -- Summer Street Research Partners is pleased to announce the recent closing of a financing for ImmunoCellular Therapeutics, Ltd. (OTC Bulletin Board: IMUC), a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The Company recently started a Phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor associated antigens for newly diagnosed glioblastoma. ImmunoCellular raised approximately $8.1 million primarily from U.S. based institutional investors. Summer Street Research Partners served as the lead placement agent for the transaction.

"Summer Street Research is very excited to be involved with ImmunoCellular, an innovative company with some of the most compelling data seen to date in Glioblastoma.  We are delighted to assist them with this financing and the interest from high quality fundamental healthcare investors," said Al Sollami, CEO of Summer Street Research Partners.

Summer Street Research Partners is an investment banking, institutional equity research and trading firm that focuses exclusively on the healthcare sector. Our mission is to help our clients maximize returns by providing the best healthcare research, ideas and investment opportunities. The firm was founded in 2002, with a culture of providing a proprietary equity research product, utilizing more than 10,000 physicians and industry professionals provided through MCRI, a division of Summer Street Research Partners. www.ssrp.com Contact: Nickolay V. Kukekov, Ph.D.Managing Director, Investment BankingSummer Street Research Partners(212)-209-3971 (o)nkukekov@ssrp.com
'/>"/>

SOURCE Summer Street Research Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Expanded Lipoprotein Testing, VAPĀ® Cholesterol Test Discussed at National Lipid Association Summer Clinical Lipid Update
2. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
3. Health Robotics and McKesson to Showcase i.v.STATION and i.v.SOFT at ASHPs Summer Meeting, Tampa, June 6-8, 2010
4. Summerhill Biomass Systems Unveils Solid Biomass Technology System at Syracuse Expo
5. ECBC Now Accepting Applications for 2009 Minority Undergraduate Summer Internship Program
6. LI-COR Updates Product and Application Guide for Summer 2008
7. NeoStem to Present at Wall Street Forum 2011 Financial Conference on Tuesday, March 1
8. Aethlon Medical to Present at the Wall Street Analyst Forum 22nd Annual Investor Conference
9. ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress
10. Abbott Wins Top Honor in Wall Street Journal Technology Innovation Awards
11. SpectraCell Contracts With Beech Street Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... UCHealth ( Aurora, Colorado ) ... nodule patient management. In addition to optimizing care coordination ... the lung, UCHealth looks to improve provider workflow by ... Stephanie Brown, RN , Thoracic Nurse Navigator, ... an Excel spreadsheet, which was extremely arduous and susceptible ...
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... 16, 2017  Windtree Therapeutics, Inc. (Nasdaq: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, ... study showed that aerosolized KL4 surfactant reduced lung ... preclinical animal model. The Company believes that these ... evidence that supports the role of KL4 surfactant ...
(Date:2/16/2017)... YORK , Feb. 16, 2017 Paradigm ... Series B financing, adding an additional $3M from New ... Mesa Verde Venture Partners and other strategic partners at ... towards further accelerating commercial adoption of their flagship Paradigm ... and expanding the Paradigm cancer registry. ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/3/2017)... Biomedical Research Institute announced that its Board of Trustees has ... Institute,s new President and CEO. Dr. Schlesinger will take the ... currently the Chair of the Department of Microbial Infection and ... at Ohio State University. "We are delighted to ... Texas Biomed," said Dr. James O. Rubin , Board ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
Breaking Biology News(10 mins):